The biologic DMARDs rituximab and abatacept were associated with an increased risk for incident cancers in patients with RA ...
While biologic treatments do not cure rheumatoid arthritis (RA), they can slow its progression. They may also cause fewer side effects than other kinds of medications. Biological response ...
Highlights in psoriatic arthritis from ACR 2024 include results of methotrexate added to DMARD therapy, responses to bimekizumab, and improvements gained by upadacitinib after prior TNF inhibitor use.
Blocking blood flow to the site of knee arthritis can reduce pain and potentially prevent the need for knee replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results